ALX Oncology Holdings Inc. (ALXO) vs Compass Therapeutics, Inc. (CMPX)
A side-by-side comparison of ALX Oncology Holdings Inc. and Compass Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALXO
ALX Oncology Holdings Inc.
$1.21HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CMPX
Compass Therapeutics, Inc.
$0.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ALXO vs CMPX
growth of $100 · dividends reinvested · last 6yALXO -98.4% (-49.6%/yr)CMPX -88.7% (-30.5%/yr)CMPX compounded faster over this window
Log scale — wide-divergence pair
ALXO CMPX
ALXO vs CMPX: by the numbers
- •CMPX is the larger company ($173M vs $163M market cap).
Metrics side by side
Valuation
| Metric | ALXO | CMPX |
|---|---|---|
| P/B ratio | 1.20 | 1.04 |
Profitability
| Metric | ALXO | CMPX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -59.40% | -44.23% |
| ROIC | -56.53% | -46.59% |
Growth (annualized)
| Metric | ALXO | CMPX |
|---|---|---|
| Total return CAGR (5Y) | -56.07% | -22.79% |
Frequently asked
- How have ALXO and CMPX total returns compared?
- Over the past 5 years, ALXO delivered -56.07% and CMPX delivered -22.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.